D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
Booking.com
BKNG
|
+$470M |
| 3 |
Qualcomm
QCOM
|
+$398M |
| 4 |
Chevron
CVX
|
+$268M |
| 5 |
Meta Platforms (Facebook)
META
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$914M |
| 2 |
Netflix
NFLX
|
+$305M |
| 3 |
Johnson & Johnson
JNJ
|
+$244M |
| 4 |
McDonald's
MCD
|
+$241M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.56% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.21% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
BrightView Holdings
BV
$1.31B
| $307K | ﹤0.01% |
+19,123
| New | +$376K |
|
3302
Southside Bancshares
SBSI
$1.02B
| $307K | ﹤0.01% |
8,810
-9,693
| -52% | -$343K |
|
3303
FB Financial Corp
FBK
$2.95B
| $306K | ﹤0.01% |
7,798
-9,206
| -54% | -$395K |
|
3304
Comtech Telecommunications
CMTL
$51.8M
| $305K | ﹤0.01% |
8,396
-13,411
| -61% | -$460K |
|
3305
TFS Financial
TFSL
$5.1B
| $305K | ﹤0.01% |
20,298
-10,456
| -34% | -$163K |
|
|
OCLR
3306
DELISTED
Oclaro Inc.
OCLR
| $304K | ﹤0.01% |
+34,022
| New | +$308K |
|
3307
Mesa Laboratories
MLAB
$539M
| $303K | ﹤0.01% |
1,634
+584
| +56% | +$118K |
|
|
GHDX
3308
PUT
DELISTED
Genomic Health, Inc.
GHDX
| $302K | ﹤0.01% |
+4,300
| New | +$252K |
|
3309
Elevance Health
ELV
$81.9B
| $301K | ﹤0.01% |
1,100
| – | – |
|
3310
Stepan Co
SCL
$1.31B
| $301K | ﹤0.01% |
3,463
-6,127
| -64% | -$528K |
|
3311
Hamilton Beach Brands
HBB
$302M
| $300K | ﹤0.01% |
13,690
+1,903
| +16% | +$48.3K |
|
|
DHC
3312
Diversified Healthcare Trust
DHC
$2.26B
| $299K | ﹤0.01% |
17,000
-141,159
| -89% | -$2.59M |
|
3313
Omnicom Group
OMC
$22.7B
| $299K | ﹤0.01% |
+4,403
| New | +$309K |
|
|
AVDL
3314
DELISTED
Avadel Pharmaceuticals
AVDL
| $297K | ﹤0.01% |
67,540
-106,121
| -61% | -$573K |
|
3315
Baytex Energy
BTE
$3.08B
| $297K | ﹤0.01% |
102,096
+39,996
| +64% | +$123K |
|
|
NFX
3316
CALL
DELISTED
Newfield Exploration
NFX
| $297K | ﹤0.01% |
+10,300
| New | +$290K |
|
3317
NovaGold Resources
NG
$2.6B
| $295K | ﹤0.01% |
79,559
-26,371
| -25% | -$106K |
|
|
ARAV
3318
DELISTED
Aravive, Inc. Common Stock
ARAV
| $295K | ﹤0.01% |
35,211
+5,693
| +19% | +$60K |
|
3319
CALL
Beazer Homes USA
BZH
$907M
| $294K | ﹤0.01% |
+28,000
| New | +$369K |
|
3320
Monolithic Power Systems
MPWR
$65.5B
| $294K | ﹤0.01% |
2,346
-67,256
| -97% | -$9.37M |
|
|
DLPH
3321
PUT
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $292K | ﹤0.01% |
+9,300
| New | +$368K |
|
|
BCPC
3322
CALL
Balchem Corp
BCPC
$5.23B
| $291K | ﹤0.01% |
+2,600
| New | +$273K |
|
3323
Accenture
ACN
$89.9B
| $290K | ﹤0.01% |
1,702
-419
| -20% | -$69.7K |
|
3324
ANI Pharmaceuticals
ANIP
$1.77B
| $288K | ﹤0.01% |
+5,094
| New | +$312K |
|
3325
CALL
Generac Holdings
GNRC
$11.9B
| $288K | ﹤0.01% |
5,100
| – | – |
|
Similar funds
D.E. Shaw & Co's Q3 2018 Portfolio in Review
As of Q3 2018, D.E. Shaw & Co held 4,167 positions worth $83.2B, up 8.6% from $76.7B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q3 2018 filing shows 494 new, 1,413 increased, 1,463 reduced and 484 closed positions. Its largest new stake was Six Flags Entertainment Corp.: 850,069 shares worth $59.4M. The largest sale was Apple, an estimated $914M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2018 buy was Six Flags Entertainment Corp.: 850,069 shares worth $59.4M.
- D.E. Shaw & Co added most to AT&T in Q3 2018, an estimated $501M increase.
- D.E. Shaw & Co's biggest Q3 2018 reduction was Apple, cutting an estimated $914M.
- D.E. Shaw & Co fully exited RH in Q3 2018, selling an estimated $43.2M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $83.2B portfolio in Q3 2018.
- D.E. Shaw & Co opened 494 new positions and closed 484 in Q3 2018.
- D.E. Shaw & Co's portfolio value rose 8.6% quarter-over-quarter to $83.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.